| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/16/1997 | US5698216 Transdermal therapeutic system for the administration of physostigmine to the skin and process for the production thereof |
| 12/16/1997 | US5698214 Prevent glucose transfer into cells |
| 12/16/1997 | US5698207 Burn treatment composition |
| 12/16/1997 | US5698190 Vinyl polymers modified with guanidino groups; effective in removing excess phosphate from the blood |
| 12/16/1997 | CA2168829C Paroxetine hydrochloride anhydrate forms a,b,c and d |
| 12/16/1997 | CA2122002C Alteration of rate and character of hair growth |
| 12/16/1997 | CA2120360C Fluoroalkylated amphiphilic ligands, their metallic complexes and their uses |
| 12/16/1997 | CA2111446C Chiral intermediates for the preparation of antidiabetics thiazoles |
| 12/16/1997 | CA2109623C Process for solubilizing difficultly soluble pharmaceutical actives |
| 12/16/1997 | CA2107479C Pyrazolo[1,5-a]pyrimidine derivatives and anti-inflammatory agent containing the same |
| 12/16/1997 | CA2086432C 3-(1-substitutedpyrazoyl)-2-oxindole derivatives |
| 12/16/1997 | CA2066249C Estradiol percutaneous administration preparations |
| 12/16/1997 | CA1339584C 2-substituted ergolines, their production and use |
| 12/14/1997 | CA2179086A1 Substituted imidazoles as modulators of multi-drug resistance |
| 12/13/1997 | CA2207464A1 Crystal of n-{(quinolin-2-yl)phenylsulfonamides and process for producing the same |
| 12/13/1997 | CA2206219A1 A novel process for the manufacture of 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo [1,5a] [1,4] benzodiazepine (midazolam) |
| 12/11/1997 | WO1997046697A3 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 12/11/1997 | WO1997046697A2 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 12/11/1997 | WO1997046694A1 Process for producing high-molecular-weight compounds of phenolic compounds, etc. and use thereof |
| 12/11/1997 | WO1997046693A1 Virus-like particles useful as a vector for delivering nucleic acid |
| 12/11/1997 | WO1997046688A1 Lipid kinase |
| 12/11/1997 | WO1997046676A1 Tumor antigen proteins, genes thereof, and tumor antigen peptides |
| 12/11/1997 | WO1997046673A2 Inhibition of hiv-1 replication by antisense rna expression |
| 12/11/1997 | WO1997046672A2 Antisense nucleic acids and hammerhead ribozymes |
| 12/11/1997 | WO1997046671A1 Enhanced efficacy of liposomal antisense delivery |
| 12/11/1997 | WO1997046649A1 Treatment of oils |
| 12/11/1997 | WO1997046585A2 Fragments of leptin (ob protein) |
| 12/11/1997 | WO1997046581A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
| 12/11/1997 | WO1997046578A1 Peptide derivatives |
| 12/11/1997 | WO1997046576A1 Anticoagulant peptidyl-arginine aldehyde derivatives |
| 12/11/1997 | WO1997046574A1 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| 12/11/1997 | WO1997046570A1 Oligoribonucleotides and ribonucleases for cleaving rna |
| 12/11/1997 | WO1997046565A1 SELECTED DERIVATIVES OF K-252a |
| 12/11/1997 | WO1997046564A1 Novel water-soluble analogues of 20(s)-camptothecin |
| 12/11/1997 | WO1997046563A1 Novel water-soluble c-ring analogues of 20 (s)-camptothecin |
| 12/11/1997 | WO1997046562A1 Novel water-soluble c-ring analogues of 20(s)-camptothecin |
| 12/11/1997 | WO1997046561A1 Improved methods for the synthesis of chemical compounds having pde-iv inhibitory activity |
| 12/11/1997 | WO1997046560A1 Amide derivatives |
| 12/11/1997 | WO1997046557A1 Cinchonan based chiral selectors for separation of stereoisomers |
| 12/11/1997 | WO1997046556A1 OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 12/11/1997 | WO1997046555A1 Imidazole-substituted quinoxalinedione derivatives |
| 12/11/1997 | WO1997046554A1 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| 12/11/1997 | WO1997046552A1 1-(1h-pyrrol-2-ylmethyl)-2-piperidone as cell migration inhibitor |
| 12/11/1997 | WO1997046551A1 Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors |
| 12/11/1997 | WO1997046549A1 Anti-neurodegeneratively effective xanthene derivatives |
| 12/11/1997 | WO1997046548A1 Dihydrobenzopyran and related compounds useful as anti-inflammatory agents |
| 12/11/1997 | WO1997046527A1 Polymorphs of donepezil hydrochloride and process for production |
| 12/11/1997 | WO1997046526A1 Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production |
| 12/11/1997 | WO1997046524A1 Novel pyrrole derivatives |
| 12/11/1997 | WO1997046522A1 Novel vitamin d analogues |
| 12/11/1997 | WO1997046521A1 Nitrate esters and their use for neurological conditions |
| 12/11/1997 | WO1997046511A1 Coumpounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 12/11/1997 | WO1997046262A2 Membrane incorporation of texaphyrins |
| 12/11/1997 | WO1997046259A2 Chimeric toxin for targeted therapy |
| 12/11/1997 | WO1997046257A1 A method for enhancing long-term memory in a subject and uses thereof |
| 12/11/1997 | WO1997046256A1 Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells |
| 12/11/1997 | WO1997046255A2 Vaccine composition comprising outer membrane protein fragments of bordetella pertussis |
| 12/11/1997 | WO1997046252A1 Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis |
| 12/11/1997 | WO1997046251A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES |
| 12/11/1997 | WO1997046247A1 Anti-tussive composition comprising essence of anise, senega dry extract and licorice root extract |
| 12/11/1997 | WO1997046246A1 Complex preparations characterised by a betain content |
| 12/11/1997 | WO1997046244A1 Compositions and method which retard the aging process and which improve age-related disease conditions |
| 12/11/1997 | WO1997046243A1 A nasal spray containing an intranasal steroid and an antihistamine |
| 12/11/1997 | WO1997046242A1 Natural progesterone for the treatment of side effects of progestins and progesterone analogues |
| 12/11/1997 | WO1997046241A1 Formulation and method for treating congestive heart failure |
| 12/11/1997 | WO1997046240A1 Compositions and methods for reducing respiratory depression |
| 12/11/1997 | WO1997046239A1 Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists |
| 12/11/1997 | WO1997046238A1 Medicaments for ameliorating endothelial cell activation |
| 12/11/1997 | WO1997046237A1 Anti-viral compounds |
| 12/11/1997 | WO1997046236A1 Anti-viral compounds |
| 12/11/1997 | WO1997046235A1 Anti-viral compounds |
| 12/11/1997 | WO1997046234A1 Pharmaceutical compositions containing mesembrine and related compounds |
| 12/11/1997 | WO1997046233A1 Use of raloxifene and of related compounds for the manufacture of a medicament for lowering plasma levels of lipoprotein(a) |
| 12/11/1997 | WO1997046232A1 7-deoxy-6-substituted paclitaxels |
| 12/11/1997 | WO1997046231A1 Oxa acids and related compounds for treating skin conditions |
| 12/11/1997 | WO1997046230A1 Method for maintaining an existing level of body fat and/or body weight |
| 12/11/1997 | WO1997046229A1 New use of derivatives of cystine |
| 12/11/1997 | WO1997046228A1 Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity |
| 12/11/1997 | WO1997046227A1 The use of buckminsterfullerene for treatment of neurotoxic injury |
| 12/11/1997 | WO1997046226A2 USE OF INHIBITORS OF THE CELLULAR Na+/H+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS |
| 12/11/1997 | WO1997046225A1 Selenophene anti-tumor agents |
| 12/11/1997 | WO1997046223A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
| 12/11/1997 | WO1997046222A1 Pediatric formulation for hiv protease inhibitors |
| 12/11/1997 | WO1997046220A1 Vegetable oil compositions |
| 12/11/1997 | WO1997046219A1 Compositions and uses thereof |
| 12/11/1997 | WO1997046209A1 Aqueous nacreous lustre concentrate |
| 12/11/1997 | WO1997046208A2 Genistein as a preventive against ultraviolet induced skin photodamage and cancer |
| 12/11/1997 | WO1997046206A2 Human thyrotropin receptor compositions and use thereof |
| 12/11/1997 | WO1997046118A1 Dietetic foods containing conjugated linoleic acids |
| 12/11/1997 | WO1997046100A1 Serpin enzyme complex receptor-mediated gene transfer |
| 12/11/1997 | WO1997041443A3 Method for screening compounds |
| 12/11/1997 | WO1997041252A3 Dna, rna and a protein useful for detection of a mycobacterial infection |
| 12/11/1997 | WO1997040017A3 Modulators of molecules with phosphotyrosine recognition units |
| 12/11/1997 | DE19622866A1 Verwendung von Opiat-Antagonisten und -Agonisten enthaltende Präparationen zur Prophylaxe und therapeutischen Behandlung von Migräne und Migräne-verwandten Erkrankungen Use of opiate antagonists and agonists containing preparations for the prophylaxis and therapeutic treatment of migraine and migraine related disorders |
| 12/11/1997 | DE19622734A1 New aminated hydroxy-alkynyl-xanthine derivatives |
| 12/11/1997 | CA2560002A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 12/11/1997 | CA2258720A1 Human thyrotropin receptor compositions and use thereof |
| 12/11/1997 | CA2257943A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
| 12/11/1997 | CA2257559A1 Complex preparations characterised by a betain content |
| 12/11/1997 | CA2257551A1 Process for producing high-molecular-weight compounds of phenolic compounds, etc. and use thereof |